Evaluation of the Ovarian Reserve in Patients Who Hypogastric Arteries and or Uterine Arteries Had Been Ligated

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02995343

Enrollment

Registered

2016-12-16

Start date

2016-11-30

Completion date

2019-09-30

Last updated

2019-03-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypogastric Artery Ligation, Ovarian Reserve, Uterine Artery Ligation

Brief summary

Patients who hypogastric arteries and/or uterine arteries had been ligated will be evaluated in terms of ovarian reserve markers such as anti-mullerian hormone levels, ovarian volumes, antral follicule count, follicule stimuli hormone and estrogen levels. Investigators will search their archives for finding suitable patients for study. Investigators will especially notice being at least 6 month time of interval between surgery and evaluation time. Ultrasound examination and taking blood sample will be performed on 2nd or 3th day of menstrual cycle. These results will be compared with normal postpartum women's results. It will be evaluated that there is or not any effect of the hypogastric arteries and/or uterine arteries on ovarian reserve

Interventions

PROCEDUREHypogastric and/or uterine artery ligation

Study design

Allocation

NON_RANDOMIZED

Intervention model

PARALLEL

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 40 Years

Healthy volunteers

Inclusion criteria

* Patients had been ligated hypogastric and/or uterine arteries * Patients are in 6 month period after surgery * Without performed hysterectomy * No older than 40 years old * No history about endocrinopathy which have an effect upon ovarian reserve

Exclusion criteria

* Patients had been made other gynecologic surgery such as fallopian tube ligation and hysterectomy etc. * Patients are older than 40 years old * Patients use drugs which have an effect upon ovarian reserve * Patients have diseases which have an effect upon ovarian reserve such as some endocrinopathy, malign diseases which require radiotherapy and chemotherapy etc.

Design outcomes

Primary

Measure	Time frame
Anti-mullerian hormone levels will be evaluated	6 months after surgery and delivery
Antral Follicule Count will be evaluated	6 months after surgery and delivery
Ovarian volume will be evaluated	6 months after surgery and delivery
Follicule Stimuli Hormone levels will be evaluated	6 months after surgery and delivery
Estrogen levels will be evaluated	6 months after surgery and delivery

Countries

Turkey (Türkiye)

Contacts

Primary Contactcagdas sahin, MD

cagdasdr@yahoo.com+905324676106

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026